0001437749-23-015170.txt : 20230518 0001437749-23-015170.hdr.sgml : 20230518 20230518185352 ACCESSION NUMBER: 0001437749-23-015170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230516 FILED AS OF DATE: 20230518 DATE AS OF CHANGE: 20230518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LeMaitre George W CENTRAL INDEX KEY: 0001365737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 23937508 MAIL ADDRESS: STREET 1: 342 BUNKER HILL STREET, #2B CITY: CHARLESTOWN STATE: MA ZIP: 02129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0407 4 2023-05-16 0001158895 LEMAITRE VASCULAR INC LMAT 0001365737 LeMaitre George W C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 1 Chairman and CEO 0 Common Stock 2023-05-16 4 M 0 8610 35.48 A 2357923 D Common Stock 2023-05-16 4 M 0 7837 37.29 A 2365760 D Common Stock 2023-05-16 4 M 0 7734 48.60 A 2373494 D Common Stock 2023-05-17 4 S 0 2143 64.05 D 2371351 D Common Stock 2023-05-17 4 S 0 33 64.82 D 2371318 D Common Stock 2023-05-18 4 S 0 17660 63.26 D 2353658 D Common Stock 2023-05-18 4 S 0 250 64.02 D 2353408 D Stock Option (Right to Buy) 35.48 2023-05-16 4 M 0 8610 0 D 2019-12-20 2026-12-20 Common Stock 8610 17220 D Stock Option (Right to Buy) 37.29 2023-05-16 4 M 0 7837 0 D 2020-12-02 2027-12-02 Common Stock 7837 23508 D Stock Option (Right to Buy) 48.60 2023-05-16 4 M 0 7734 0 D 2021-12-11 2028-12-11 Common Stock 7734 23200 D Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $63.77 to $64.47 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $62.94 to $63.92 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $63.94 to $64.27 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years with the final vesting occurring on the eleventh month after the fourth anniversary. This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. /s/ Val Gertz 2023-05-18